Fig. 8From: Glioma-targeted oxaliplatin/ferritin clathrate reversing the immunosuppressive microenvironment through hijacking Fe2+ and boosting Fenton reactionThe therapeutic effect of OXA@Fn on orthotopic TMZ-resistant glioma in mice. A The inhibitory effect of OXA@Fn on the growth of orthotopic TMZ-resistant glioma observed by in vivo bioluminescence imaging. B Statistical analysis of orthotopic TMZ-resistant glioma growth. (n = 5, mean ± SD, *P < 0.05, **P < 0.01). C Effects of OXA@Fn on the body weight of orthotopic TMZ-resistant glioma mice. (n = 10, mean ± SD, *P < 0.05, **P < 0.01). D Effects of OXA@Fn on the survival time of orthotopic TMZ-resistant glioma mice. (n = 10, mean ± SD, *P < 0.05, **P < 0.01). E The H&E stainning of orthotopic TMZ-resistant glioma tissue slicesBack to article page